English
简体中文
Total: £ 56.28
Published Date: 2026-02-06 | Pages: 140 | Tables: 146 | Pharma & Healthcare
The global Steroidal MRAs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Steroidal MRAs competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Steroidal Mineralocorticoid Receptor Antagonists (MRAs) are a class of medications that inhibit the action of mineralocorticoid hormones, primarily aldosterone, by binding to mineralocorticoid receptors in the kidneys and other tissues.Common examples include spironolactone and eplerenone, which are used for their diuretic effects and to manage conditions like heart failure and primary aldosteronism.
The market for Steroidal Mineralocorticoid Receptor Antagonists (MRAs) has experienced significant growth over recent years, driven by the increasing prevalence of conditions such as hypertension, heart failure, and primary aldosteronism. The rise in chronic diseases, particularly cardiovascular disorders, has led to a greater demand for effective treatments, fueling the expansion of the MRA market. Pharmaceutical advancements and the introduction of new formulations and dosages have further contributed to market growth, providing more tailored treatment options for patients.
In addition to increasing patient populations, the market is also influenced by ongoing research and development efforts aimed at improving the efficacy and safety profiles of steroidal MRAs. Innovations in drug delivery systems and combination therapies are enhancing the therapeutic benefits of these medications. Regulatory approvals for new MRA drugs and indications are also driving market expansion by broadening the therapeutic applications of these agents.
Despite the positive market trends, challenges such as competition from non-steroidal MRAs and potential side effects of steroidal MRAs pose hurdles to market growth. Nonetheless, the overall outlook remains robust, with continued innovation and expanding indications likely to sustain growth in the steroidal MRA market.
This report delivers a comprehensive overview of the global Steroidal MRAs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Steroidal MRAs. The Steroidal MRAs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Steroidal MRAs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Steroidal MRAs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Pfizer
Accord Healthcare
Zydus
Sun Pharmaceuticals
Amneal Pharmaceuticals
Actavis Elizabeth
Mylan
Sandoz
Kyorin Rimedio
Viatris Pharmaceuticals
MSN
Camber Pharmaceuticals
Jiangsu Yunyang Pharmaceutical Group
Grand Pharmaceutical
Suzhou Homesun Pharmaceutical
Sinopharm Zhonglian Pharmaceutical
Chongqing Kerui Pharmaceutical
Hangzhou Minsheng Pharmaceutical
Jiangsu Chia Tai Fenghai Pharmaceutical
Jiangsu Changjiang Pharmaceutical
Yatai Pharma
Shanghai Xinyi Wanxiang pharmaceutical
Segment by Type
Spironolactone
Eplerenone
by Application
Heart failure
Hypertension
Edema
Aldosteronism
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Steroidal MRAs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Steroidal MRAs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Steroidal MRAs Market Overview
1.1 Product Definition
1.2 Steroidal MRAs by Type
1.2.1 Global Steroidal MRAs Market Value by Type: 2025 vs 2032
1.2.2 Spironolactone
1.2.3 Eplerenone
1.3 Steroidal MRAs by Application
1.3.1 Global Steroidal MRAs Market Value by Application: 2025 vs 2032
1.3.2 Heart failure
1.3.3 Hypertension
1.3.4 Edema
1.3.5 Aldosteronism
1.3.6 Others
1.4 Global Steroidal MRAs Market Size Estimates and Forecasts
1.4.1 Global Steroidal MRAs Revenue 2021–2032
1.4.2 Global Steroidal MRAs Sales 2021–2032
1.4.3 Global Steroidal MRAs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Steroidal MRAs Market Competition by Manufacturers
2.1 Global Steroidal MRAs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Steroidal MRAs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Steroidal MRAs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Steroidal MRAs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Steroidal MRAs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Steroidal MRAs, Product Types and Applications
2.7 Global Key Manufacturers of Steroidal MRAs, Date of Entry into the Industry
2.8 Global Steroidal MRAs Market Competitive Situation and Trends
2.8.1 Global Steroidal MRAs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Steroidal MRAs Players Market Share by Revenue
2.8.3 Global Steroidal MRAs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Steroidal MRAs Market Scenario by Region
3.1 Global Steroidal MRAs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Steroidal MRAs Sales by Region: 2021–2032
3.2.1 Global Steroidal MRAs Sales by Region: 2021–2026
3.2.2 Global Steroidal MRAs Sales by Region: 2027–2032
3.3 Global Steroidal MRAs Revenue by Region: 2021–2032
3.3.1 Global Steroidal MRAs Revenue by Region: 2021–2026
3.3.2 Global Steroidal MRAs Revenue by Region: 2027–2032
3.4 North America Steroidal MRAs Market Facts & Figures by Country
3.4.1 North America Steroidal MRAs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Steroidal MRAs Sales by Country (2021–2032)
3.4.3 North America Steroidal MRAs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Steroidal MRAs Market Facts & Figures by Country
3.5.1 Europe Steroidal MRAs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Steroidal MRAs Sales by Country (2021–2032)
3.5.3 Europe Steroidal MRAs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Steroidal MRAs Market Facts & Figures by Region
3.6.1 Asia Pacific Steroidal MRAs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Steroidal MRAs Sales by Region (2021–2032)
3.6.3 Asia Pacific Steroidal MRAs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Steroidal MRAs Market Facts & Figures by Country
3.7.1 Latin America Steroidal MRAs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Steroidal MRAs Sales by Country (2021–2032)
3.7.3 Latin America Steroidal MRAs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Steroidal MRAs Market Facts & Figures by Country
3.8.1 Middle East and Africa Steroidal MRAs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Steroidal MRAs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Steroidal MRAs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Steroidal MRAs Sales by Type (2021–2032)
4.1.1 Global Steroidal MRAs Sales by Type (2021–2026)
4.1.2 Global Steroidal MRAs Sales by Type (2027–2032)
4.1.3 Global Steroidal MRAs Sales Market Share by Type (2021–2032)
4.2 Global Steroidal MRAs Revenue by Type (2021–2032)
4.2.1 Global Steroidal MRAs Revenue by Type (2021–2026)
4.2.2 Global Steroidal MRAs Revenue by Type (2027–2032)
4.2.3 Global Steroidal MRAs Revenue Market Share by Type (2021–2032)
4.3 Global Steroidal MRAs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Steroidal MRAs Sales by Application (2021–2032)
5.1.1 Global Steroidal MRAs Sales by Application (2021–2026)
5.1.2 Global Steroidal MRAs Sales by Application (2027–2032)
5.1.3 Global Steroidal MRAs Sales Market Share by Application (2021–2032)
5.2 Global Steroidal MRAs Revenue by Application (2021–2032)
5.2.1 Global Steroidal MRAs Revenue by Application (2021–2026)
5.2.2 Global Steroidal MRAs Revenue by Application (2027–2032)
5.2.3 Global Steroidal MRAs Revenue Market Share by Application (2021–2032)
5.3 Global Steroidal MRAs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Pfizer Steroidal MRAs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Accord Healthcare
6.2.1 Accord Healthcare Company Information
6.2.2 Accord Healthcare Description and Business Overview
6.2.3 Accord Healthcare Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Accord Healthcare Steroidal MRAs Product Portfolio
6.2.5 Accord Healthcare Recent Developments/Updates
6.3 Zydus
6.3.1 Zydus Company Information
6.3.2 Zydus Description and Business Overview
6.3.3 Zydus Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Zydus Steroidal MRAs Product Portfolio
6.3.5 Zydus Recent Developments/Updates
6.4 Sun Pharmaceuticals
6.4.1 Sun Pharmaceuticals Company Information
6.4.2 Sun Pharmaceuticals Description and Business Overview
6.4.3 Sun Pharmaceuticals Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Sun Pharmaceuticals Steroidal MRAs Product Portfolio
6.4.5 Sun Pharmaceuticals Recent Developments/Updates
6.5 Amneal Pharmaceuticals
6.5.1 Amneal Pharmaceuticals Company Information
6.5.2 Amneal Pharmaceuticals Description and Business Overview
6.5.3 Amneal Pharmaceuticals Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Amneal Pharmaceuticals Steroidal MRAs Product Portfolio
6.5.5 Amneal Pharmaceuticals Recent Developments/Updates
6.6 Actavis Elizabeth
6.6.1 Actavis Elizabeth Company Information
6.6.2 Actavis Elizabeth Description and Business Overview
6.6.3 Actavis Elizabeth Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Actavis Elizabeth Steroidal MRAs Product Portfolio
6.6.5 Actavis Elizabeth Recent Developments/Updates
6.7 Mylan
6.7.1 Mylan Company Information
6.7.2 Mylan Description and Business Overview
6.7.3 Mylan Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Mylan Steroidal MRAs Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Sandoz
6.8.1 Sandoz Company Information
6.8.2 Sandoz Description and Business Overview
6.8.3 Sandoz Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sandoz Steroidal MRAs Product Portfolio
6.8.5 Sandoz Recent Developments/Updates
6.9 Kyorin Rimedio
6.9.1 Kyorin Rimedio Company Information
6.9.2 Kyorin Rimedio Description and Business Overview
6.9.3 Kyorin Rimedio Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Kyorin Rimedio Steroidal MRAs Product Portfolio
6.9.5 Kyorin Rimedio Recent Developments/Updates
6.10 Viatris Pharmaceuticals
6.10.1 Viatris Pharmaceuticals Company Information
6.10.2 Viatris Pharmaceuticals Description and Business Overview
6.10.3 Viatris Pharmaceuticals Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Viatris Pharmaceuticals Steroidal MRAs Product Portfolio
6.10.5 Viatris Pharmaceuticals Recent Developments/Updates
6.11 MSN
6.11.1 MSN Company Information
6.11.2 MSN Description and Business Overview
6.11.3 MSN Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 MSN Steroidal MRAs Product Portfolio
6.11.5 MSN Recent Developments/Updates
6.12 Camber Pharmaceuticals
6.12.1 Camber Pharmaceuticals Company Information
6.12.2 Camber Pharmaceuticals Description and Business Overview
6.12.3 Camber Pharmaceuticals Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Camber Pharmaceuticals Steroidal MRAs Product Portfolio
6.12.5 Camber Pharmaceuticals Recent Developments/Updates
6.13 Jiangsu Yunyang Pharmaceutical Group
6.13.1 Jiangsu Yunyang Pharmaceutical Group Company Information
6.13.2 Jiangsu Yunyang Pharmaceutical Group Description and Business Overview
6.13.3 Jiangsu Yunyang Pharmaceutical Group Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Jiangsu Yunyang Pharmaceutical Group Steroidal MRAs Product Portfolio
6.13.5 Jiangsu Yunyang Pharmaceutical Group Recent Developments/Updates
6.14 Grand Pharmaceutical
6.14.1 Grand Pharmaceutical Company Information
6.14.2 Grand Pharmaceutical Description and Business Overview
6.14.3 Grand Pharmaceutical Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Grand Pharmaceutical Steroidal MRAs Product Portfolio
6.14.5 Grand Pharmaceutical Recent Developments/Updates
6.15 Suzhou Homesun Pharmaceutical
6.15.1 Suzhou Homesun Pharmaceutical Company Information
6.15.2 Suzhou Homesun Pharmaceutical Description and Business Overview
6.15.3 Suzhou Homesun Pharmaceutical Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Suzhou Homesun Pharmaceutical Steroidal MRAs Product Portfolio
6.15.5 Suzhou Homesun Pharmaceutical Recent Developments/Updates
6.16 Sinopharm Zhonglian Pharmaceutical
6.16.1 Sinopharm Zhonglian Pharmaceutical Company Information
6.16.2 Sinopharm Zhonglian Pharmaceutical Description and Business Overview
6.16.3 Sinopharm Zhonglian Pharmaceutical Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Sinopharm Zhonglian Pharmaceutical Steroidal MRAs Product Portfolio
6.16.5 Sinopharm Zhonglian Pharmaceutical Recent Developments/Updates
6.17 Chongqing Kerui Pharmaceutical
6.17.1 Chongqing Kerui Pharmaceutical Company Information
6.17.2 Chongqing Kerui Pharmaceutical Description and Business Overview
6.17.3 Chongqing Kerui Pharmaceutical Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Chongqing Kerui Pharmaceutical Steroidal MRAs Product Portfolio
6.17.5 Chongqing Kerui Pharmaceutical Recent Developments/Updates
6.18 Hangzhou Minsheng Pharmaceutical
6.18.1 Hangzhou Minsheng Pharmaceutical Company Information
6.18.2 Hangzhou Minsheng Pharmaceutical Description and Business Overview
6.18.3 Hangzhou Minsheng Pharmaceutical Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Hangzhou Minsheng Pharmaceutical Steroidal MRAs Product Portfolio
6.18.5 Hangzhou Minsheng Pharmaceutical Recent Developments/Updates
6.19 Jiangsu Chia Tai Fenghai Pharmaceutical
6.19.1 Jiangsu Chia Tai Fenghai Pharmaceutical Company Information
6.19.2 Jiangsu Chia Tai Fenghai Pharmaceutical Description and Business Overview
6.19.3 Jiangsu Chia Tai Fenghai Pharmaceutical Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Jiangsu Chia Tai Fenghai Pharmaceutical Steroidal MRAs Product Portfolio
6.19.5 Jiangsu Chia Tai Fenghai Pharmaceutical Recent Developments/Updates
6.20 Jiangsu Changjiang Pharmaceutical
6.20.1 Jiangsu Changjiang Pharmaceutical Company Information
6.20.2 Jiangsu Changjiang Pharmaceutical Description and Business Overview
6.20.3 Jiangsu Changjiang Pharmaceutical Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Jiangsu Changjiang Pharmaceutical Steroidal MRAs Product Portfolio
6.20.5 Jiangsu Changjiang Pharmaceutical Recent Developments/Updates
6.21 Yatai Pharma
6.21.1 Yatai Pharma Company Information
6.21.2 Yatai Pharma Description and Business Overview
6.21.3 Yatai Pharma Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Yatai Pharma Steroidal MRAs Product Portfolio
6.21.5 Yatai Pharma Recent Developments/Updates
6.22 Shanghai Xinyi Wanxiang pharmaceutical
6.22.1 Shanghai Xinyi Wanxiang pharmaceutical Company Information
6.22.2 Shanghai Xinyi Wanxiang pharmaceutical Description and Business Overview
6.22.3 Shanghai Xinyi Wanxiang pharmaceutical Steroidal MRAs Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Shanghai Xinyi Wanxiang pharmaceutical Steroidal MRAs Product Portfolio
6.22.5 Shanghai Xinyi Wanxiang pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Steroidal MRAs Industry Chain Analysis
7.2 Steroidal MRAs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Steroidal MRAs Production Mode & Process Analysis
7.4 Steroidal MRAs Sales and Marketing
7.4.1 Steroidal MRAs Sales Channels
7.4.2 Steroidal MRAs Distributors
7.5 Steroidal MRAs Customer Analysis
8 Steroidal MRAs Market Dynamics
8.1 Steroidal MRAs Industry Trends
8.2 Steroidal MRAs Market Drivers
8.3 Steroidal MRAs Market Challenges
8.4 Steroidal MRAs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Steroidal MRAs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Steroidal MRAs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Steroidal MRAs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Steroidal MRAs Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Steroidal MRAs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Steroidal MRAs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Steroidal MRAs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Steroidal MRAs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Steroidal MRAs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Steroidal MRAs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Steroidal MRAs, Product Types and Applications
Table 12. Global Key Manufacturers of Steroidal MRAs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Steroidal MRAs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Steroidal MRAs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Steroidal MRAs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Steroidal MRAs Sales by Region (K Units), 2021–2026
Table 18. Global Steroidal MRAs Sales Market Share by Region (2021–2026)
Table 19. Global Steroidal MRAs Sales by Region (K Units), 2027–2032
Table 20. Global Steroidal MRAs Sales Market Share by Region (2027–2032)
Table 21. Global Steroidal MRAs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Steroidal MRAs Revenue Market Share by Region (2021–2026)
Table 23. Global Steroidal MRAs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Steroidal MRAs Revenue Market Share by Region (2027–2032)
Table 25. North America Steroidal MRAs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Steroidal MRAs Sales by Country (K Units), 2021–2026
Table 27. North America Steroidal MRAs Sales by Country (K Units), 2027–2032
Table 28. North America Steroidal MRAs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Steroidal MRAs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Steroidal MRAs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Steroidal MRAs Sales by Country (K Units), 2021–2026
Table 32. Europe Steroidal MRAs Sales by Country (K Units), 2027–2032
Table 33. Europe Steroidal MRAs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Steroidal MRAs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Steroidal MRAs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Steroidal MRAs Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Steroidal MRAs Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Steroidal MRAs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Steroidal MRAs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Steroidal MRAs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Steroidal MRAs Sales by Country (K Units), 2021–2026
Table 42. Latin America Steroidal MRAs Sales by Country (K Units), 2027–2032
Table 43. Latin America Steroidal MRAs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Steroidal MRAs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Steroidal MRAs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Steroidal MRAs Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Steroidal MRAs Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Steroidal MRAs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Steroidal MRAs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Steroidal MRAs Sales (K Units) by Type (2021–2026)
Table 51. Global Steroidal MRAs Sales (K Units) by Type (2027–2032)
Table 52. Global Steroidal MRAs Sales Market Share by Type (2021–2026)
Table 53. Global Steroidal MRAs Sales Market Share by Type (2027–2032)
Table 54. Global Steroidal MRAs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Steroidal MRAs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Steroidal MRAs Revenue Market Share by Type (2021–2026)
Table 57. Global Steroidal MRAs Revenue Market Share by Type (2027–2032)
Table 58. Global Steroidal MRAs Price (US$/Unit) by Type (2021–2026)
Table 59. Global Steroidal MRAs Price (US$/Unit) by Type (2027–2032)
Table 60. Global Steroidal MRAs Sales (K Units) by Application (2021–2026)
Table 61. Global Steroidal MRAs Sales (K Units) by Application (2027–2032)
Table 62. Global Steroidal MRAs Sales Market Share by Application (2021–2026)
Table 63. Global Steroidal MRAs Sales Market Share by Application (2027–2032)
Table 64. Global Steroidal MRAs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Steroidal MRAs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Steroidal MRAs Revenue Market Share by Application (2021–2026)
Table 67. Global Steroidal MRAs Revenue Market Share by Application (2027–2032)
Table 68. Global Steroidal MRAs Price (US$/Unit) by Application (2021–2026)
Table 69. Global Steroidal MRAs Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer Steroidal MRAs Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Accord Healthcare Company Information
Table 76. Accord Healthcare Description and Business Overview
Table 77. Accord Healthcare Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Accord Healthcare Steroidal MRAs Product
Table 79. Accord Healthcare Recent Developments/Updates
Table 80. Zydus Company Information
Table 81. Zydus Description and Business Overview
Table 82. Zydus Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Zydus Steroidal MRAs Product
Table 84. Zydus Recent Developments/Updates
Table 85. Sun Pharmaceuticals Company Information
Table 86. Sun Pharmaceuticals Description and Business Overview
Table 87. Sun Pharmaceuticals Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Sun Pharmaceuticals Steroidal MRAs Product
Table 89. Sun Pharmaceuticals Recent Developments/Updates
Table 90. Amneal Pharmaceuticals Company Information
Table 91. Amneal Pharmaceuticals Description and Business Overview
Table 92. Amneal Pharmaceuticals Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Amneal Pharmaceuticals Steroidal MRAs Product
Table 94. Amneal Pharmaceuticals Recent Developments/Updates
Table 95. Actavis Elizabeth Company Information
Table 96. Actavis Elizabeth Description and Business Overview
Table 97. Actavis Elizabeth Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Actavis Elizabeth Steroidal MRAs Product
Table 99. Actavis Elizabeth Recent Developments/Updates
Table 100. Mylan Company Information
Table 101. Mylan Description and Business Overview
Table 102. Mylan Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Mylan Steroidal MRAs Product
Table 104. Mylan Recent Developments/Updates
Table 105. Sandoz Company Information
Table 106. Sandoz Description and Business Overview
Table 107. Sandoz Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Sandoz Steroidal MRAs Product
Table 109. Sandoz Recent Developments/Updates
Table 110. Kyorin Rimedio Company Information
Table 111. Kyorin Rimedio Description and Business Overview
Table 112. Kyorin Rimedio Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Kyorin Rimedio Steroidal MRAs Product
Table 114. Kyorin Rimedio Recent Developments/Updates
Table 115. Viatris Pharmaceuticals Company Information
Table 116. Viatris Pharmaceuticals Description and Business Overview
Table 117. Viatris Pharmaceuticals Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. Viatris Pharmaceuticals Steroidal MRAs Product
Table 119. Viatris Pharmaceuticals Recent Developments/Updates
Table 120. MSN Company Information
Table 121. MSN Description and Business Overview
Table 122. MSN Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. MSN Steroidal MRAs Product
Table 124. MSN Recent Developments/Updates
Table 125. Camber Pharmaceuticals Company Information
Table 126. Camber Pharmaceuticals Description and Business Overview
Table 127. Camber Pharmaceuticals Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Camber Pharmaceuticals Steroidal MRAs Product
Table 129. Camber Pharmaceuticals Recent Developments/Updates
Table 130. Jiangsu Yunyang Pharmaceutical Group Company Information
Table 131. Jiangsu Yunyang Pharmaceutical Group Description and Business Overview
Table 132. Jiangsu Yunyang Pharmaceutical Group Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Jiangsu Yunyang Pharmaceutical Group Steroidal MRAs Product
Table 134. Jiangsu Yunyang Pharmaceutical Group Recent Developments/Updates
Table 135. Grand Pharmaceutical Company Information
Table 136. Grand Pharmaceutical Description and Business Overview
Table 137. Grand Pharmaceutical Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Grand Pharmaceutical Steroidal MRAs Product
Table 139. Grand Pharmaceutical Recent Developments/Updates
Table 140. Suzhou Homesun Pharmaceutical Company Information
Table 141. Suzhou Homesun Pharmaceutical Description and Business Overview
Table 142. Suzhou Homesun Pharmaceutical Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Suzhou Homesun Pharmaceutical Steroidal MRAs Product
Table 144. Suzhou Homesun Pharmaceutical Recent Developments/Updates
Table 145. Sinopharm Zhonglian Pharmaceutical Company Information
Table 146. Sinopharm Zhonglian Pharmaceutical Description and Business Overview
Table 147. Sinopharm Zhonglian Pharmaceutical Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Sinopharm Zhonglian Pharmaceutical Steroidal MRAs Product
Table 149. Sinopharm Zhonglian Pharmaceutical Recent Developments/Updates
Table 150. Chongqing Kerui Pharmaceutical Company Information
Table 151. Chongqing Kerui Pharmaceutical Description and Business Overview
Table 152. Chongqing Kerui Pharmaceutical Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Chongqing Kerui Pharmaceutical Steroidal MRAs Product
Table 154. Chongqing Kerui Pharmaceutical Recent Developments/Updates
Table 155. Hangzhou Minsheng Pharmaceutical Company Information
Table 156. Hangzhou Minsheng Pharmaceutical Description and Business Overview
Table 157. Hangzhou Minsheng Pharmaceutical Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Hangzhou Minsheng Pharmaceutical Steroidal MRAs Product
Table 159. Hangzhou Minsheng Pharmaceutical Recent Developments/Updates
Table 160. Jiangsu Chia Tai Fenghai Pharmaceutical Company Information
Table 161. Jiangsu Chia Tai Fenghai Pharmaceutical Description and Business Overview
Table 162. Jiangsu Chia Tai Fenghai Pharmaceutical Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Jiangsu Chia Tai Fenghai Pharmaceutical Steroidal MRAs Product
Table 164. Jiangsu Chia Tai Fenghai Pharmaceutical Recent Developments/Updates
Table 165. Jiangsu Changjiang Pharmaceutical Company Information
Table 166. Jiangsu Changjiang Pharmaceutical Description and Business Overview
Table 167. Jiangsu Changjiang Pharmaceutical Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Jiangsu Changjiang Pharmaceutical Steroidal MRAs Product
Table 169. Jiangsu Changjiang Pharmaceutical Recent Developments/Updates
Table 170. Yatai Pharma Company Information
Table 171. Yatai Pharma Description and Business Overview
Table 172. Yatai Pharma Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 173. Yatai Pharma Steroidal MRAs Product
Table 174. Yatai Pharma Recent Developments/Updates
Table 175. Shanghai Xinyi Wanxiang pharmaceutical Company Information
Table 176. Shanghai Xinyi Wanxiang pharmaceutical Description and Business Overview
Table 177. Shanghai Xinyi Wanxiang pharmaceutical Steroidal MRAs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 178. Shanghai Xinyi Wanxiang pharmaceutical Steroidal MRAs Product
Table 179. Shanghai Xinyi Wanxiang pharmaceutical Recent Developments/Updates
Table 180. Key Raw Materials Lists
Table 181. Raw Materials Key Suppliers Lists
Table 182. Steroidal MRAs Distributors List
Table 183. Steroidal MRAs Customers List
Table 184. Steroidal MRAs Market Trends
Table 185. Steroidal MRAs Market Drivers
Table 186. Steroidal MRAs Market Challenges
Table 187. Steroidal MRAs Market Restraints
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
Table 191. Authors List of This Report
List of Figures
Figure 1. Product Picture of Steroidal MRAs
Figure 2. Global Steroidal MRAs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Steroidal MRAs Market Share by Type: 2025 & 2032
Figure 4. Spironolactone Product Picture
Figure 5. Eplerenone Product Picture
Figure 6. Global Steroidal MRAs Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Steroidal MRAs Market Share by Application: 2025 & 2032
Figure 8. Heart failure
Figure 9. Hypertension
Figure 10. Edema
Figure 11. Aldosteronism
Figure 12. Others
Figure 13. Global Steroidal MRAs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Steroidal MRAs Market Size (US$ Million), 2021–2032
Figure 15. Global Steroidal MRAs Sales (K Units), 2021–2032
Figure 16. Global Steroidal MRAs Average Price (US$/Unit), 2021–2032
Figure 17. Steroidal MRAs Report Years Considered
Figure 18. Steroidal MRAs Sales Share by Manufacturers in 2025
Figure 19. Global Steroidal MRAs Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global Steroidal MRAs Players: Market Share by Revenue in Steroidal MRAs in 2025
Figure 21. Steroidal MRAs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global Steroidal MRAs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America Steroidal MRAs Sales Market Share by Country (2021–2032)
Figure 24. North America Steroidal MRAs Revenue Market Share by Country (2021–2032)
Figure 25. United States Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe Steroidal MRAs Sales Market Share by Country (2021–2032)
Figure 28. Europe Steroidal MRAs Revenue Market Share by Country (2021–2032)
Figure 29. Germany Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific Steroidal MRAs Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific Steroidal MRAs Revenue Market Share by Region (2021–2032)
Figure 36. China Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Steroidal MRAs Sales Market Share by Country (2021–2032)
Figure 44. Latin America Steroidal MRAs Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa Steroidal MRAs Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa Steroidal MRAs Revenue Market Share by Country (2021–2032)
Figure 51. Turkey Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE Steroidal MRAs Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of Steroidal MRAs by Type (2021–2032)
Figure 55. Global Revenue Market Share of Steroidal MRAs by Type (2021–2032)
Figure 56. Global Steroidal MRAs Price (US$/Unit) by Type (2021–2032)
Figure 57. Global Sales Market Share of Steroidal MRAs by Application (2021–2032)
Figure 58. Global Revenue Market Share of Steroidal MRAs by Application (2021–2032)
Figure 59. Global Steroidal MRAs Price (US$/Unit) by Application (2021–2032)
Figure 60. Steroidal MRAs Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
